You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
4 July 2025 - Global biopharmaceutical company AstraZeneca (LSE/STO/NASDAQ:AZN) announced on Friday that it has received European Union approval for Imfinzi (durvalumab) as the first and only perioperative immunotherapy for adult patients with resect...
4 July 2025 - INOVIO Pharmaceuticals Inc (Nasdaq:INO), a US-based biotechnology company involved in developing and commercialising DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, announced on...
4 July 2025 - BioLab Holdings Inc, a US-based medical manufacturer specialising in wound healing and regenerative therapies, announce on Thursday the launch of a multicentre hybrid platform trial evaluating the clinical effectiveness of its amnion-ba...
4 July 2025 - India-based biosimilars company Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, announced on Thursday that the European Commission has granted marketing authorisation in the European Union for its Vevzuo and Evfraxy biosimilars ...
3 July 2025 - Dizal (SSE:688192), a China-based biopharmaceutical company involved in developing novel medicines for the treatment of cancer and immunological diseases, announced on Wednesday that the US Food and Drug Administration (FDA) has approve...
3 July 2025 - Apotex Inc., a Canada-based global health company, announced on Wednesday that Health Canada has approved Aflivu (aflibercept), a biosimilar to Eylea, indicated for the treatment of neovascular (wet) age-related macular degeneration, ma...
3 July 2025 - Jacobio Pharma (1167.HK), a China-based pharmaceutical company, announced on Wednesday that it has submitted the Phase I/II Investigational New Drug (IND) application for its BET inhibitor JAB-8263 for the treatment of autoimmune diseas...